Corporate Governance

As a single company, INC and inVentiv will offer end-to-end solutions to support drug development and commercialization. (Image: iStock/AndreyPopov)

INC Research, inVentiv merger 'a perfect fit'

By Melissa Fassbender

INC Research and inVentiv Health are merging to create one of the largest biopharmaceutical outsourcing providers – and a “top three CRO,” says CEO.

Hiring and Firing Jan '17

PEOPLE ON THE MOVE

Hiring and Firing Jan '17

By Dani Bancroft

Welcome to in-PharmaTechnologist's monthly round up of who's been moving where in the small-molecule manufacturing world. The CEO of BMS is moving internally, Axim Biotechnologies and Pharmalink have new board members, whilst Vium and Dova Pharmaceuticals...

Who's going places in pharma?

people on the move

Who's on the move?

By Fiona BARRY

The WHO Executive Board prepares for a special Ebola meeting, CEO leaves troubled biotech, and senior staff hired at Bayer and Immunocore...

Pharma People: New Board Member at BMS

Pharma People: New Board Member at BMS

By Dan Stanton

BMS have appointed a new director and ex Shire-CEO joins Questcor - yes, you've guessed it, it's in-Pharmatechnologist.com's weekly pharma people round-up.

People on the Move: Jobs in Pharma

People on the Move: Jobs in Pharma

By Dan Stanton

In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.

People on the Move: Jobs in Pharma

People on the Move: Jobs in Pharma

By Dan Stanton

In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.

Roche appointing Genentech’s CEO to lead its pharma division and Mylan’s CFO leaving after three months in the job – People on the move

Roche appointing Genentech’s CEO to lead its pharma division and Mylan’s CFO leaving after three months in the job – People on the move

By Nick Taylor

in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Roche appointing Genentech’s CEO to lead its pharma division and Mylan’s CFO leaving after three months in the job.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All